For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/candid-conversations-about-menopause-treatment-barriers-9387SummaryJoin Dr. Genevieve Neil-Perry as she moderates a dynamic panel discussion on the obstacles hindering access to quality menopause treatment. Dr. Gregg Sherman (primary care) and Dr. Nanette Santoro (OB/GYN) bring their clinical perspectives, while a patient joins and shares their firsthand experiences.This episode explores the unique challenges faced by patients and providers within the menopause care landscape. The panel delves into potential solutions, aiming to empower listeners with knowledge and strategies to overcome these barriers for improved menopause care.Learning ObjectiveIdentify patient and clinician barriers to management of menopausal symptomsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which does not include hours of pharmacology ).For additional information about the accreditation of this program, contact NACE at info@naceonline.com.Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:Consultant: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity), Boehringer Ingelheim (obesity), WW (obesity), Gelesis (obesity - relationship has ended)Speaker: Novo Nordisk (obesity), Lilly (obesity), Acella (thyroid), Currax (obesity)Receipt of Royalty: Springer (obesity - relationship has ended), Amazon (fiction)Guest Patient has no relevant financial relationships to disclose.Bernadette Makar has no relevant financial relationships to disclose.Gregg Sherman has no relevant financial relationships to disclose.Genevieve Neal-Perry has disclosed the following financial relationships:Scientific Advisory Board: Astellas (women’s health), Natera (women’s health)Review Panel: SRI (professional organization)Nanette Santoro has disclosed the following financial relationships:Consultant: Astellas Pharma, MenoGeniX, Ansh LabsAll disclosures are related to women's health.All of the relevant financial relationships listed for these individuals have been mitigated. Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial SupportThis educational activity isPlease visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a) Guest:Brad Rivotto, MDResident – Family Medicine Residency ProgramJefferson Health – Abington 2. Triple – Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 TrialJulio Rosenstock, MDSenior Scientific Advisor for Velocity Clinical Research,Director of Velocity’s site at Medical City Dallas,Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas.3. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.Amrin Syed, DO Resident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestCori Fratelli, RN, MSN, FNP-CNurse PractitionerDivision of Pulmonary, Critical Care & Sleep MedicineDepartment of MedicineI have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Long-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US AdultsGuest:Philip Lieberman, MD, Resident – Family Medicine Residency Program Jefferson Health – Abington 2. Association between changes in carbohydrate intake and long term weight changes: prospective cohort studyWalter C. Willett, M.D., Dr. P.H.Professor of Epidemiology and Nutrition at Harvard T.H. Chan School of Public Health, Professor of Medicine, Harvard Medical School3. Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-AnalysisRichard Potter, MD, Resident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestCori Fratelli, RN, MSN, FNP-CNurse PractitionerDivision of Pulmonary, Critical Care & Sleep Medicine Department of MedicineI have a unique background in both basic science and clinical research, which has informed my interest in clinical medicine. My past basic science research includes asthma, airway hyperresponsiveness, cystic fibrosis, and lung cancer. My past clinical research includes COPD and interstitial lung disease (ILD). Presently, I am interested in how research translates into personalized medicine. My clinical focus is mainly ILD, but I also see general pulmonary medicine patients, as needed. HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial Guest:Amy Clouse, MDAssociate DirectorFamily Medicine ResidencyJefferson Health – Abington.  2. Association Between Changes in Carbohydrate Intake and Long Term Weight Changes: Prospective Cohort StudyGuest:Walter C. Willett, MD, PhDProfessor of Epidemiology and NutritionHarvard T.H. Chan School of Public Health 3. Guidelines of care for the management of atopic dermatitis in adults with topical therapies – Journal of the American Academy of DermatologyGuest: Catherine McCormick, DO  Resident in the Family Medicine ResidencyJefferson Health – Abington.  Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial –The New England Journal of MedicineGuest:Marrisa Norden, DOResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PA2. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation ARandomized Clinical Trial - JAMAGuest:Richard Potter, MDResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PA3. Sedentary Behavior and Incident Dementia Among Older Adults - JAMAGuest: Michael Devano, DOResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PAMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answering-questions-about-homozygous-familial-hypercholesterolemia-9140Featuring faculty Zahid Ahmad, MD, FNLA, and Don Wilson, MD SummaryHomozygous familial hypercholesterolemia (FH) is a rare but critical genetic disorder characterized by extremely high LDL cholesterol levels, significantly increasing the risk of early cardiovascular disease. In this activity, Dr. Zahid Ahmad and Dr. Don Wilson provide expert insights into homozygous FH, answering questions from recent live-virtual symposia. They cover crucial topics, including diagnosis, pediatric lipid screening, genetic testing, and care coordination. The experts emphasize the significance of specialized care and early intervention for individuals with homozygous FH, aiming to better inform healthcare professionals and improve patient outcomes.Learning ObjectivesUpon completion of this activity, learners should be able to: Diagnose HoFH based on clinical criteria and genetic testing when indicatedImplement, or refer patients for, cascade screening and the appropriate pharmacologic treatment of HoFHRecognize and address patient and family needs to overcome barriers to care in HoFHThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which include 0 hours of pharmacology).Click on the link to view the summary of individual disclosures.https://www.naceonline.com/courses/deep-dive-into-five-answering-your-questions-about-hofhDisclosure of Commercial SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestSusan Wilxon, MD Dr. Susan Wilcox, M.D., attended medical school at Washington University School of Medicine and trained in Emergency Medicine in the Harvard Affiliated Emergency Medicine Residency, graduating in 2008. After residency, she completed an Anesthesia Critical Care fellowship at Massachusetts General Hospital.  Since finishing her training in 2009, she divided her time between the Emergency Department and critical care, working in Surgical ICUs, Medical ICUs, and long-term vent units. In July 2017, she assumed the role of the Chief of the newly formed Division of Critical Care within the Department of Emergency Medicine MGH. In addition to attending in the Emergency Department, she also attends in the Heart Center ICU and serves as the Associate Chief Medical Officer of Boston MedFlight.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/using-glp-1-ras-to-reduce-cv-risk-in-t2d-9134SummaryType 2 diabetes (T2D) doubles a patient’s risk for atherosclerotic cardiovascular disease (ASCVD), which is the leading cause of morbidity and mortality in patients with T2D. The 2023 ADA guidelines now recommend consideration of GLP-1 RAs in patients with T2D and ASCVD or indicators of ASCVD risk, independently of A1C and metformin use. In this episode, Dr. Pam Taub reviews recent updates in the cardiovascular benefits and appropriate use of GLP-1 receptor agonists for managing patients with T2D.Learning Objectives Incorporate early use of GLP-1 RA therapy in appropriate patients with T2D using a holistic approach, considering administration route and optimal dosingOvercome barriers to GLP-1 RA uptake and medication adherence in T2D through patient counseling to manage adverse effectsThis activity is accredited for CME/CE CreditAssociation of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Association of Black Cardiologists, Inc. (ABC) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and ABC. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, contact NACE at info@naceonline.com.Summary of Individual DisclosuresDr. Taub financial relationships:Consultant: Amgen, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Esperion, Merck, Sanofi, Medtronic Contracted Research: Amgen, Novartis All her disclosures are related to cardiologyDr. Morris financial relationships: Consultant and advisor: Acorai, Regeneron, MerckSpeaker: Abbott, BI Lilly, Cytokinetics, Edwards Lifesciences, Ionis Contracted Research: Boston Scientific, Cytokinetics, Ionis, Merck, Myokardia, Novartis Stocks: Gilead Sciences All her disclosures are related to heart failure.All of the relevant financial relationships listed for these individuals have been mitigated.Association of Black Cardiologists Planning CommitteeTierra Dillenburg has no relevant conflicts of interest with any ACCME-defined commercial interest.Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial Support This educational activity is supported by an independent educational grant from Novo Nordisk Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestMartha Kingman, FNP-C, DNP Family Nurse Practitioner in the pulmonary hypertension clinic at the University of Texas Southwestern Medical Center at Dallas. She is presently serving as sub-investigator in numerous ongoing pulmonary hypertension clinical trials. She is a member of the speakers’ bureaus for Actelion, United Therapeutics, and Gilead, and she gives her time and expertise to several nursing advisory boards. Martha is an active member of the PH Professional Network, having previously served on the national conference planning committee, and she has chaired the Research and Publications Committee of the Pulmonary Hypertension Association. She currently serves on the Editorial Board of Advances in Pulmonary Hypertension, the PHA’s journal.Dr. Kingman earned a bachelor’s degree from Tulsa University School of Nursing in Tulsa, following which she worked in emergency department settings as a staff nurse and then as director of the ED after which she obtained her Master of Science in Nursing degree from Texas Woman’s University in Dallas. When she became board certified as a Family Nurse Practitioner, she accepted the job of nurse practitioner in the pulmonary department at UTSW Medical Center and remains in that role today.  The majority of her clinical work involves the follow-up outpatient care of a large group of pulmonary hypertension patients at UTSW Medical Center. In May 2011, Dr. Kingman obtained her Doctorate in Nursing Practice from Texas Christian University.Martha has published in the area of pulmonary hypertension and has spoken at local and national conferences.  Her main area of research interest involves the safety of intravenous prostacyclins in the hospital setting.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestRebecca Prebe, Nurse PractitionerHostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesNACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestJoanne Wozniak HudsonNeed more information here..... Can't find bio online.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/managing-tardive-dyskinesia-9045Featuring faculty Gregory Mattingly, MD, moderated by Gregg Sherman, MD.SummaryBesides identification of patients with Tardive Dyskinesia (TD), management options have not always provided much, if any, relief. Traditional approaches to managing TD were not only questionable, and some were potentially harmful, but the availability of newer medications has ushered in a new era in TD management. In this activity, discuss management principles and review two cases to put TD management into practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveUpon completion of this activity, learners should be able to:Individualize the management of TD using evidence-based strategies that target uncontrolled movementsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:Consultant: SetPoint (obesity), WW (obesity)Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)Speaker: Currax (obesity), Novo Nordisk (obesity)Receipt of Royalty: Amazon (fiction books), Springer (obesity book)Greg Mattingly has disclosed the following financial relationship:Consultant: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intra-Cellular, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, TevaSpeaker: AbbVie, Alkermes, Axsome, Corium, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris PharmaContracted Research: AbbVie, Alkermes, Akili, Axsome, Boehringer Ingelheim, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine Biosciences, NLS Pharmaceuticals, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, TevaAll his disclosures are related to mental healthFaculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial Support This activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/whos-at-risk-for-tardive-dyskinesia-9044 Featuring faculty Gregory Mattingly, MD, moderated by Gregg Sherman, MD. SummaryTardive Dyskinesia (TD) exerts a profound negative impact across a patient’s life, including physical and cognitive domains and psychosocial functioning. This affects quality of life (QoL), increases hospitalizations and is associated with speech and eating difficulties, decreased employment, social withdrawal, stigmatization, and amplified emotional distress. In this podcast, hear from a patient who suffered with TD for years before diagnose, and discuss how to identify and support patients with TD.Learning ObjectivesUpon completion of this activity, learners should be able to:Identify the early manifestations of tardive dyskinesia (TD) in patients on antipsychotic therapyRecognize the burden associated with untreated TD and the consequences of delayed diagnosisThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:Consultant: SetPoint (obesity), WW (obesity)Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)Speaker: Currax (obesity), Novo Nordisk (obesity)Receipt of Royalty: Amazon (fiction books), Springer (obesity book)Greg Mattingly has disclosed the following financial relationship:Consultant: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intra-Cellular, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, TevaSpeaker: AbbVie, Alkermes, Axsome, Corium, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris PharmaContracted Research: AbbVie, Alkermes, Akili, Axsome, Boehringer Ingelheim, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine Biosciences, NLS Pharmaceuticals, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, TevaAll his disclosures are related to mental healthFaculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial Support This activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/expert-interpretations-in-asthma-care-9014SummaryCase discussions help translate clinical and research findings to the real world, and two pulmonologists’ perspectives on biologic selection and management in real world cases only furthers understand. Walk through two cases with Dr. Njira Lugogo and Dr. Diego Maselli moderated by NACE’s Dr Gregg Sherman. What would YOU do, when you hear the case presentations? Do the experts agree?Learning Objectives Review emerging data, including real-world and long-term extension studies, on biologic treatments for patients with severe asthma.Individualize biologic therapy selection for patients with severe asthma based on phenotype, comorbidities, and patient preferences.This activity is accredited for CME/CE Credit.Provided by the National Association for Continuing Education in partnership with the Association for Pulmonary Advanced Practice Providers.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 contact hour (which includes 0.5 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresDr. Lugogo has disclosed the following financial relationship:Consultant: Amgen, AstraZeneca, Avillion, Genentech, GSK, Novartis, Regeneron, Sanofi, and TevaAdvisor: Amgen, AstraZeneca, Genentech, GSK, Regeneron, Sanofi, and TevaSpeaker: Honoraria for non-speaker’s bureau presentations from GSK and AstraZenecaContracted Research: Research support from Amgen, AstraZeneca, Avillion, Evidera, Gossamer Bio, Genentech, GSK, Janssen (COVID vaccine trials), Regeneron, Sanofi, Novartis and Teva was provided to my institutionAll of her disclosures are related to asthma.Dr. Maselli has disclosed the following financial relationships:Consultant: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)Advisor: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)Speaker: Amgen (asthma), Regeneron/Sanofi (asthma), AstraZeneca (asthma, COPD), GSK (asthma, COPD)Dr. Sherman has no relevant financial relationships to disclose.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesAll is not as it seems? Dr. Alain Eid’s passion for research and years of experience as a principal investigator on innumerable studies helps us learn how to pick apart research articles and not to take them at face value. Take a deeper dive and strengthen your knowledge in evidence based medicine.NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestAlain Eid, MDAlain Eid, MD is a 1991 graduate from St. Joseph University Medical School (Lebanon). He received his Medical school training in the hospitals of Paris, France. He completed his residency in Internal Medicine at St. John Hospital, Detroit. He finished his fellowship in Pulmonary Medicine and Critical Care at the Oklahoma University Medical Center. He was appointed Associate Professor of Pulmonary and Critical Care Medicine from 1998 through 2004 at the Oklahoma University. He is board Certified in Critical Care, Pulmonary Medicine and Sleep Medicine. Dr. Eid has a special interest and vast experience in lung cancer diagnosis and management. He developed the Lung nodule Clinic/ Lung cancer center at the VA of Oklahoma City. Once in Colorado Springs, he championed the development of the lung Cancer Center at Memorial Hospital and then at Penrose Hospital.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show NotesThis episode is packed full of recommendations to help you make the most of your visits with your COPD patients.Nurse Practitioner Alanna Kavanaugh, who works with the American Lung Association’s COPD Advisory Board and has been part of the international GOLD Guideline updates Joins Corinne to discuss guidelines and best practices in the management of your COPD patients. NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestAlanna Kavanaugh, EdD(c), FNP-BC, MSN, BSN, CCRNAlanna Kavanaugh is a Board certified Family Nurse Practitioner. She received her master’s degree from the College of Mount Saint Vincent. She is currently pursuing her Doctorate of Nursing Education at Columbia University, Teachers College. She is a Graduate Program Chair and Director of the Family Nurse Practitioner Program at her alma mater, the College of Mount Saint Vincent. Under her leadership, she has restructured the curriculum to improve student outcomes and created several innovative programs to improve student success. Her work improved Board Certification Rates above 90% for first time test takers. Her innovative programs provide a strong clinical foundation for the world’s future clinicians and her programs aid in smooth student transition to practice.HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers.In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/itch-scratch-immunotherapies-for-prurigo-nodularis-8912Featuring faculty Shawn Kwatra, MD, moderated by Gregg Sherman, MDSummaryPrurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe, unrelenting pruritus that is higher in intensity and associated with greater decrease in quality of life (QoL) than with other pruritic dermatoses such as atopic dermatitis and psoriasis. Patients with PN report severe disturbances in sleep, reduced participation in social activities, and absenteeism from work because of their disease. Outcomes with traditional treatments for PN are variable and unpredictable but novel and emerging therapies, that target the underlying pathophysiology of PN, offer patients opportunities for an improved quality of life.In this second of two podcast episodes, Dr. Shawn Kwatra and Dr. Gregg Sherman discuss the pathophysiology of PN and how to incorporate recently approved and emerging therapies into the management of this condition. Joining them is a real patient with PN to share their journey and the impact of systemic therapy.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesUpon completion of this activity, learners should be able to:Describe the role of neuroimmune dysregulation in the pathophysiology of PNIndividualize therapy for patients with PN based on the best available evidence, including recent clinical trial dataThis activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).Click on the link to view the summary of individual disclosures.https://docs.naceonline.com/wp-content/uploads/sites/16/2023/07/Summary-of-Individual-Disclosures.pdfDisclosure of Commercial SupportThis educational activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/itching-scratching-diagnosing-prurigo-nodularis-8910Featuring faculty Shawn Kwatra, MD, moderated by Gregg Sherman, MD.SummaryPrurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe, unrelenting pruritus that is higher in intensity and associated with greater decrease in quality of life (QoL) than with other pruritic dermatoses such as atopic dermatitis and psoriasis. Patients with PN report severe disturbances in sleep, reduced participation in social activities, and absenteeism from work because of their disease.In this first of two podcast episodes, Dr. Shawn Kwatra and Dr. Gregg Sherman discuss the presentation and diagnosis of PN. Joining them is a real patient with PN to share their experience and journey.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveUpon completion of this activity, learners should be able to:Identify the clinical manifestations and differential workup associated with the accurate, timely diagnosis of prurigo nodularis (PN)This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Click on the link to view the summary of individual disclosures.https://docs.naceonline.com/wp-content/uploads/sites/16/2023/07/Summary-of-Individual-Disclosures.pdfDisclosure of Commercial SupportThis educational activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.